
The randomized, multicenter crossover study evaluates the Carry Life UF system, a novel steady concentration peritoneal dialysis (SCPD) method, in home settings. Nineteen patients across Europe will compare Carry Life UF with standard 2.27% CAPD over two 4-week periods. Primary outcomes include ultrafiltration (UF) volume, with secondary measures such as sodium removal and glucose efficiency. Results aim to support safe, effective home dialysis innovations.
Like
Save
Share